The Petri Dish: Verve’s base editing is being tested in humans, Moderna updates boosters again


Verve Therapeutics Inc. hit a major milestone when it tested its base-editing gene therapy in vivo — that is, inside the human body — for the first time.

Previous Heart murmur-detecting Oakland digital health company Eko lands fifth FDA OK
Next Louisville Burger Week is back — here's where to get the deals